ArticleJournal of inflammation research2021

Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma-COPD Overlap in vivo and in vitro.

Shuyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.